ARTICLES BY THIS AUTHOR
- 10/21/2008
Voltaren Emulgel: nonprescription topical NSAID
Novartis Consumer Healthcare is introducing the first nonprescription topical nonsteroidal anti-inflammatory drug to be marketed in Canada. - 10/21/2008
Study takes a stab at vaccinations
Researchers at public health agencies for Quebec City and the province, and at Université Laval's pharmacy faculty are examining vaccination services in community pharmacies. - 10/20/2008
Are hair products safe during pregnancy?
Pregnant women, particularly those exposed through their occupation, may inquire about the safety of exposure to hair products while pregnant. - 10/20/2008
Health Canada takes action on bisphenol A
Health Canada is drafting legislation to prohibit the importation, sale and advertising of polycarbonate baby bottles that contain bisphenol A. - 10/15/2008
Oral health: important to overall health
A new section of the Veterans Affairs Canada website reinforces the importance of maintaining good oral health in order to optimize overall health in seniors. - 10/14/2008
Codeine-breastfeeding safety information
Health Canada is advising consumers and healthcare professionals about the rare, but potentially serious risk to infants when women take codeine-containing products while breastfeeding. - 10/8/2008
Canadian Health Consumer Index rates each province's healthcare system
Ontario came in first in the Frontier Centre for Public Policy's first annual Canada Health Consumer Index which was released today. - 10/8/2008
Head lice: updated statement
The Canadian Paediatric Society has issued a revised statement on the diagnosis and management of head lice. - 10/7/2008
Association recognized for anti-meth program
On October 4 at the National Conference of the Canadian Society of Association Executives (CSAE) in Vancouver, NDMAC was presented with the Associations Make a Better Canada award. - 10/6/2008
Revlimid approved for multiple myeloma
Celgene's Revlimid (lenalidomide 15 mg and 25 mg capsules) is now indicated for the treatment of multiple myeloma (in combination with dexamethasone) in patients who have received at least one prior therapy.